NCT04461171Recruiting
Enhanced Recovery After Surgery in Extremity Sarcoma
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 10 Jun 2020
- Start date
- 14 Dec 2020
- Primary completion date
- Dec 2026
- Lead sponsor
- Joshua Lawrenz
- Diseases
- Sarcoma
- NCT number
- NCT04461171
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 14 Dec 2020 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients treated non-operatively
- Non-English speaking patients
Who the study is looking for
- Any patient at Vanderbilt University Medical Center treated with surgical excision of a suspected extremity sarcoma
- Adult patients \>17 years of age
- Patients of all preoperative opioid status (naïve or dependent)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vanderbilt University Medical Center Coordinator of this site? Confirm its status | Nashville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.